The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Finding Opportunity Through Challenge: Q&A with Vaneet K. Sandhu, MD, FACR, RhMSUS

Finding Opportunity Through Challenge: Q&A with Vaneet K. Sandhu, MD, FACR, RhMSUS

April 17, 2020 • By Carina Stanton

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Vaneet K. Sandhu, MD, FACR, RhMSUS

The COVID-19 global pandemic is forcing telemedicine-only connections with patients and bringing existing rheumatology research to a standstill. However, these challenges are spurring opportunity and innovation, according to Vaneet K. Sandhu, MD, FACR, RhMSUS, director of rheumatology clinical operations at Riverside University Health System and associate fellowship program director in rheumatology at Loma Linda University Medical Center, Calif. She spoke with The Rheumatologist about how the pandemic is affecting her clinic and research.

You Might Also Like
  • How to Maintain Connections with Colleagues, Staff & Patients During a Pandemic: A Q&A with Reshma Khan, MD
  • Adjusting Patient Care to Social Distancing: Q&A with Bryant Uy, MPH, PA-C
  • New Processes May Stick Around After the Pandemic: Q&A with Wendy Ramey, BSPharm, RPh, CSP
Also By This Author
  • RISE Dashboard Updates Help Users Report 2018 MIPS Data

Q: How are you and your staff adapting to the sudden changes brought about by the pandemic?
The practice of medicine has changed dramatically in the last four weeks. Although some of our staff are working from remote locations and others are still going to the hospitals and clinics, we continue to work together as a team with frequent telephone and video contact. We have far more virtual meetings than before, and it seems as though we’re actually making more contact with one another than before this pandemic—it’s interesting. Nonetheless, there’s nothing quite like that physical interaction with one another.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Additionally, our division has assisted with establishing an algorithm to manage cytokine release syndrome, a complication that can be seen with COVID-19 infection. With this [project], we have established a biologic stewardship program to promote appropriate use of biologics.

Q: How is your research being affected by COVID-19?
Unfortunately, my research has come to a near standstill. I cannot bring patients in for physical examination, which is key in many rheumatology research studies. Even a video visit, although better, can be limiting.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

I have been able to continue telephone follow-ups with patients as needed. But truth be told, the mood and effect of the pandemic has also impacted my bandwidth to conduct research. Despite a hold on my prior research, however, I now seek answers to new questions, particularly the role of our treatments in managing cytokine release syndrome due to COVID-19 infection. So with every closed door opens an opportunity for something more.

Q: What types of appointments are you conducting and what are patients’ chief concerns regarding COVID-19’s potential risks and symptoms?
In our practice, we have spent the past six months trying to set up telemedicine. However, within days of the shelter-in-place orders, we managed to have all services set up. So patients and providers are continuing with their appointments remotely with minimal disruption in care. At this time, we’re doing both video visits, as well as telephone visits, at each of our institutions.

Pages: 1 2 | Single Page

Filed Under: Practice Management, Professional Topics Tagged With: coronavirus, COVID-19, Research, telemedicine

You Might Also Like:
  • How to Maintain Connections with Colleagues, Staff & Patients During a Pandemic: A Q&A with Reshma Khan, MD
  • Adjusting Patient Care to Social Distancing: Q&A with Bryant Uy, MPH, PA-C
  • New Processes May Stick Around After the Pandemic: Q&A with Wendy Ramey, BSPharm, RPh, CSP
  • Transitioning to a Virtual Practice: Q&A with Lisa Criscione-Schreiber, MD, MEd

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)